相关实验视频

Updated: Mar 3, 2026

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

作为胰腺癌的预后标记物,维丁表达:系统性审查和元分析

Oana-Iulia Cretu¹, Cristian Virgil Lungulescu², Manuel Gentiluomo³

¹Department of Pathology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Craiova, Romania.

Frontiers in medicine

|March 2, 2026

概括

胰腺癌中的维丁表达与较差的存活率和淋巴结扩散有关. 然而,高异质性和潜在偏差意味着其作为独立生物标志物的使用需要更标准化的研究.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物标志物研究生物标志物研究

背景情况:

维丁与胰腺管腺癌 (PDAC) 的进展有关.
关于维门丁在PDAC中的预后价值的临床数据不一致.
这项研究系统地审查了维门丁与PDAC临床病理特征的关联.

研究的目的:

在PDAC中量化瘤细胞维门丁表达的预后意义.
评估维门丁与整体存活率 (OS) 之间的关系.
为了评估维门丁与瘤阶段,淋巴结和转移状态的关联.

主要方法:

在PubMed,Web of Science和Scopus的系统文献搜索.
使用危险比率 (HRs) 和几率比率 (ORs) 的九项选定的研究的元分析.
评估异质性 (I2,Q测试) 和出版偏差 (漏斗图).

主要成果:

维门丁表达显著与减少的OS相关 (logHR=1.39,p=0.034) 但具有很高的异质性.
维门丁与较高的淋巴结阶段 (logOR=0.58,p=0.022) 与低异质性显著相关.
维门丁与T阶段或M阶段之间没有发现显著的关联.

结论:

瘤细胞维门丁表达是PDAC中较差的OS和淋巴结参与的显著预后指标.
高异质性和潜在的出版偏见需要谨慎解释.
需要标准化,以澄清维门丁作为独立生物标志物的临床实用性.

关键词:

这是一个元分析.转移转移转移转移总体存活率总体存活率胰腺癌是一种癌症.在这里,你会看到Vimentin.

更多相关视频

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...